135 related articles for article (PubMed ID: 26118190)
1. Validity of Tissue Microarray by Immunohistochemistry.
Fujita H; Takayama T; Takaoka N; Tan C; Igarashi H; Sugimura H; Ozono S
Clin Lab; 2015; 61(5-6):569-74. PubMed ID: 26118190
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarrays: one size does not fit all.
Eckel-Passow JE; Lohse CM; Sheinin Y; Crispen PL; Krco CJ; Kwon ED
Diagn Pathol; 2010 Jul; 5():48. PubMed ID: 20609235
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines.
Takaoka N; Takayama T; Teratani T; Sugiyama T; Mugiya S; Ozono S
BMC Mol Biol; 2011 Jul; 12():31. PubMed ID: 21771320
[TBL] [Abstract][Full Text] [Related]
5. Tissue microarrays from renal cell tumors: exclusion criteria and rate of exclusion.
Hager M; Kolbitsch C; Tiefenthaler W; Haufe H; Kemmerling R; Lucia Moser P
Scand J Urol Nephrol; 2007; 41(6):485-9. PubMed ID: 17853046
[TBL] [Abstract][Full Text] [Related]
6. Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Virchows Arch; 2004 Dec; 445(6):631-6. PubMed ID: 15517366
[TBL] [Abstract][Full Text] [Related]
7. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
Lin F; Zhang PL; Yang XJ; Shi J; Blasick T; Han WK; Wang HL; Shen SS; Teh BT; Bonventre JV
Am J Surg Pathol; 2007 Mar; 31(3):371-81. PubMed ID: 17325478
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
[TBL] [Abstract][Full Text] [Related]
9. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarray technology and findings for diagnostic immunohistochemistry.
van Zwieten A
Pathology; 2013 Jan; 45(1):71-9. PubMed ID: 23222246
[TBL] [Abstract][Full Text] [Related]
11. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology.
Knoepp SM; Kunju LP; Roh MH
Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis.
Leite KR; Reis ST; Junior JP; Zerati M; Gomes Dde O; Camara-Lopes LH; Srougi M
Diagn Pathol; 2015 Oct; 10():189. PubMed ID: 26470780
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CD10 and renal cell carcinoma marker in clear cell renal cell carcinoma: analysis on tissue arrays].
Ortiz-Rey JA; Gómez De María C; Peláez Boismorand E; Fernández Costas A; Barbosa Barreiro MJ; Antón Badiola I
Actas Urol Esp; 2006 Mar; 30(3):281-6. PubMed ID: 16749584
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of glucose transporters in human renal cell carcinoma.
Nagase Y; Takata K; Moriyama N; Aso Y; Murakami T; Hirano H
J Urol; 1995 Mar; 153(3 Pt 1):798-801. PubMed ID: 7861542
[TBL] [Abstract][Full Text] [Related]
15. Validation of a low-cost modified technique for constructing tissue microarrays for canine mammary tumor analysis.
Silva FB; Leite Jda S; de Mello MF; Ferreira AM
Pathol Res Pract; 2016 Sep; 212(9):783-90. PubMed ID: 27461825
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
17. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
Mantilla JG; Antic T; Tretiakova M
Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients.
Duensing S; Dallmann I; Grosse J; Buer J; Lopez Hänninen E; Deckert M; Störkel S; Kirchner H; Poliwoda H; Atzpodien J
Oncology; 1994; 51(4):309-13. PubMed ID: 7911563
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 and P53 in renal cell carcinoma: association with tumor subtypes.
Noroozinia F; Fahmideh AN; Yekta Z; Rouhrazi H; Rasmi Y
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):79-84. PubMed ID: 24434386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
